Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2014-01-01Self-monitoring in hypertension: A web-based survey of primary care physiciansMcManus, RJ; Wood, S; Bray, EP; Glasziou, P; Hayen, A; Heneghan, C; Mant, J; Padfield, P; Potter, JF; Hobbs, FDR
2018-01-01Legacy effects of statins on cardiovascular and all-cause mortality: A meta-analysisNayak, A; Hayen, A; Zhu, L; McGeechan, K; Glasziou, P; Irwig, L; Doust, J; Gregory, G; Bell, K
2013-10-07General practitioners' use of different cardiovascular risk assessment strategies: a qualitative studyBonner, C; Jansen, J; McKinn, S; Irwig, L; Doust, J; Glasziou, P; Hayen, A; McCaffery, K
2011-01-29Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial dataBell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P
2014-01-01Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study dataBell, KJL; Beller, E; Sundström, J; McGeechan, K; Hayen, A; Irwig, L; Neal, B; Glasziou, P
2014-01-01General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: An experimental studyJansen, J; Bonner, C; McKinn, S; Irwig, L; Glasziou, P; Doust, J; Teixeira-Pinto, A; Hayen, A; Turner, R; McCaffery, K
2017-01-17Change in bone mineral density is an indicator of treatment-related antifracture effectBell, KJL; Hayen, A; Glasziou, P; Irwig, L; Bauer, DC
2019-03-01Lifetime risk of prostate cancer overdiagnosis in Australia: Quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approachPathirana, T; Hayen, A; Doust, J; Glasziou, P; Bell, K
2013-05-04When to remeasure cardiovascular risk in untreated people at low and intermediate risk: Observational studyBell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P
2017-03EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial Data.Bell, KJL; Hayen, A; Glasziou, P; Mitchell, AS; Farris, M; Wright, J; Duerr, H-P; Mitchell, P; Irwig, L
Results 1-10 of 10 (Search time: 0.015 seconds).
  • previous
  • 1
  • next